Latest News and Press Releases
Want to stay updated on the latest news?
-
BOSTON, MA--(Marketwired - Jan 23, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that a decision to grant a...
-
BOSTON, MA--(Marketwired - Jan 14, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that the Canadian...
-
BOSTON, MA--(Marketwired - Jan 9, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today the grant and issuance of...
-
BOSTON, MA--(Marketwired - Jan 3, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, announced today that Philip C. Ranker will...
-
BOSTON, MA and AUSTIN, TX--(Marketwired - Jan 2, 2014) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading oligonucleotide-based drug discovery and development company, and Mirna Therapeutics,...
-
CAMBRIDGE, MA--(Marketwired - Aug 14, 2013) - Marina Biotech, Inc. (PINKSHEETS: MRNA) Assigns Unlocked Nucleobase Analog (UNA) patents to Arcturus but retains...
-
BOTHELL, WA--(Marketwired - May 13, 2013) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the...
-
BOTHELL, WA--(Marketwire - Dec 6, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading RNAi-based drug discovery and development company, yesterday reported financial results for the...
-
BOTHELL, WA--(Marketwire - Dec 5, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the Company's licensee,...
-
BOTHELL, WA--(Marketwire - Dec 4, 2012) - Marina Biotech, Inc. (PINKSHEETS: MRNA), a leading nucleic acid-based drug discovery and development company, today announced that the U.S. Patent and...